4//SEC Filing
Berelowitz Michael 4
Accession 0001192482-18-000109
CIK 0001588972other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:15 PM ET
Size
11.7 KB
Accession
0001192482-18-000109
Insider Transaction Report
Form 4
Berelowitz Michael
Director
Transactions
- Exercise/Conversion
Common Stock
2018-03-09$2.47/sh+7,500$18,525→ 7,500 total - Exercise/Conversion
Stock Option (right to buy)
2018-03-09−7,500→ 14,500 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (7,500 underlying) - Sale
Common Stock
2018-03-09$10.45/sh−7,500$78,347→ 0 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.411 to $10.5053, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
- [F2]The option vested on December 17, 2015.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001493383
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:15 PM ET
- Size
- 11.7 KB